As Founding President of the nonprofit corporation, BioMed SA, Ann Stevens brings a unique combination of experience in the biomedical field, investment community and media industry – along with a collaborative leadership style and a passion for community service – to her role of promoting and growing San Antonio’s leading industry, healthcare and the biosciences.
She holds a B.A. degree in journalism from Texas State University (formerly Southwest Texas State University), graduating with highest honors, and was named a Distinguished Alumna in 2013.
Before accepting her leadership role with BioMed SA in 2005, Stevens spent eight years as Director of Corporate Communications and Investor Relations for ILEX Oncology, Inc., San Antonio’s first publicly traded biopharmaceutical company. She was a key member of the leadership team that raised the market capitalization of this homegrown, startup company from under $100 million to its final acquisition price by Genzyme Corporation of $1 billion in December 2004.